Confidential — For Land Partner Review

Pure Extracts LLC
Land Partnership
ROI Analysis

Projected returns, setup timeline, and investment structure for on-site botanical extraction operations.

Prepared byChristopher Shearer, Pure Extracts LLC
DateApril 2026
Projection Period24 Months
Your Cash Investment$50,000
At a Glance

24-Month Financial Summary

Total Revenue (24 mo)
$1.58M
Starting at $1,500/mo current baseline
Net Retained Profit
$886K
After all salaries, COGS, and fees
Operational Breakeven
Month 6
First month of positive net cash flow
Capital Recovery
Month 12
Full $50K investment returned
Gross Margin (at scale)
68%
Reaches 68% by Month 19 (bulk purchasing)
Setup Timeline
2–4 mo
Container buildout + permitting
Market Opportunity

Blue Lotus and Kanna Are Multi-Industry Products

Most supplement companies sell into one market. Blue lotus and kanna simultaneously qualify for eight distinct high-growth market categories. That's not a niche play — it's multiple addressable markets with the same SKU. Layered on top of that: the most favorable US regulatory environment for botanical supplements since 1994, a pharmaceutical cost crisis creating active demand for alternatives, and a social media awareness curve that mirrors kratom's early years exactly.

Industries Blue Lotus & Kanna Sell Into

Industry2024 Market Size2030 ProjectionHow These Products Fit
Herbal Supplements (US) $13.2B $22–25B Direct category — tinctures, capsules, dried herb, gummies
Nootropics / Cognitive Enhancement $5.3B global $14B+ Kanna is a PDE-4 inhibitor — clinically studied for memory, focus, and cognitive function
Adaptogens $9.4B global $20B+ Both compounds fit the adaptogen profile; ashwagandha proved this category scales to mass retail
Anxiety & Mood Supplements $6.2B (US) $9.6B Kanna inhibits serotonin reuptake and PDE-4 — the same dual mechanism as prescription antidepressants, no Rx required
Sleep & Relaxation Market $11B (US) $18B+ Blue lotus has been used as a sleep and relaxation aid for 5,000+ years; direct placement in sleep stacks
Functional Beverages $10B botanical slice Rapid growth Blue lotus teas, tonics, and ritual beverages are an emerging category; kanna being trialed in nootropic drinks
Luxury Skincare / Cosmetics $200B+ global Growing Nymphaea caerulea (blue lotus) extract is an active ingredient in premium skincare lines for anti-aging and hydration
Ceremonial & Plant Medicine Emerging Rapid Blue lotus is the most widely used legal plant in ceremonial and plant medicine communities — demand growing alongside psychedelic therapy awareness
Smoke Shop / Ethnobotanical Retail 30,000+ US shops Active now The same retail infrastructure that took kratom from zero to $2B — already stocked, customer-educated, and searching for new botanical SKUs
Blue Lotus & Kanna — Global vs. US Market 2024 (USD Millions)
The Kratom Blueprint — Unknown to $2B (2010–2024)
The Kratom Blueprint
Kratom was unknown outside Southeast Asian immigrant communities in 2010. By 2024: a $2B+ US industry, 15 million users, 17%+ annual CAGR. The pattern is consistent for every botanical that crosses over — ethnobotanical awareness, online community adoption, smoke shop distribution, then mainstream supplement retail. Blue lotus and kanna are on that same curve, roughly where kratom was in 2013. The advantage: both compounds are federally unscheduled with no pending DEA action, whereas kratom spent years fighting scheduling attempts that suppressed mainstream retail adoption. The infrastructure, the moment, and the regulatory runway are all in better shape now than kratom had in its early years.
Political Tailwind — MAHA, RFK Jr. & FDA Reform
RFK Jr. as HHS Secretary has made botanical supplements and natural alternatives an explicit federal priority. Concrete 2025–2026 actions: removed restrictive designations from compounding-pharmacy ingredients, proposed eliminating mandatory structure-function claim disclaimers on supplement labels, and shifted FDA enforcement attention away from natural products. This is the most favorable federal posture toward botanical supplements since the Dietary Supplement Health and Education Act of 1994. At the same time, 43% of Americans cannot fill their prescriptions due to cost, and 72% say drug pricing regulation is insufficient — that's tens of millions of people actively looking for alternatives. Kanna as a natural serotonin reuptake inhibitor is not a fringe product in this environment. It's a direct answer to a mass-market problem.
Revenue & Profitability

Monthly Revenue Trajectory

Why the curve looks like this

Revenue starts at $1,500/month — actual current baseline from existing wholesale accounts. The curve is driven by one variable: sales volume. The product and distribution infrastructure already exist. The land-based container facility removes the current bottleneck (commercial kitchen rental limits batch size and scheduling). Growth is modeled in four phases: ~45% monthly in M1–6 (early account wins + container launch), 30% monthly in M7–12 (wholesale pipeline active), 15% monthly in M13–18 (maturing accounts), and 10% monthly in M19–24 (stable scale).

Monthly Revenue vs. Net Profit — Months 1–24

Cumulative Revenue & Profit Accumulation

Cost Structure at Scale (Month 18+)

Cost of Goods Sold

COGS Compression via Bulk Purchasing

COGS declines as volume scales because the primary inputs — vegetable glycerin, cane alcohol, botanical extracts, bottles, and labels — all have significant bulk pricing breaks. The shift from gallon-scale to drum-scale purchasing alone drives a 10–12 point COGS reduction.

Phase 1 — Current Small Batch (Months 1–6)

Now
COGS
26.5%
Commission + Fees
17.0%
Contribution Margin
56.5%

Phase 2 — Gallon/Case Scale (Months 7–12)

Growing
COGS
22.0%
Commission + Fees
17.0%
Contribution Margin
61.0%

Phase 3 — First Drum Buys (Months 13–18)

Scaling
COGS
18.0%
Commission + Fees
17.0%
Contribution Margin
65.0%

Phase 4 — Full Drum + Equipment (Months 19–24)

Optimized
COGS
15.0%
Commission + Fees
17.0%
Contribution Margin
68.0%

COGS % by Phase — Bulk Purchasing Impact

Ingredient Cost Drivers (Current Small Batch)

Production Capability

Daily Output — Container Kitchen

Production is not the constraint. Sales is. The container facility can outpace the current sales pipeline on day one — meaning every new wholesale account and every platform listing translates directly to revenue with no production bottleneck. Numbers below reflect one operator running production while 2–4 packagers work in parallel.

Gummies
1,000–2,000
finished 10-packs per day
(10,000–20,000 individual gummies)
Elixir Bottles
1,000+
units per day
Tincture Bottles
1,000+
units per day
Resin & Dried Herb
Ready to ship
Bulk-sourced, packaged on demand
What this means for the revenue model

At Month 12 projected revenue (~$46,800/month), the operation is running at roughly 5–10% of daily production capacity. The facility can support 10x current Month 12 revenue without a single additional equipment purchase. Growth is gated entirely by sales volume, not the ability to fill orders.

Monthly Detail

24-Month P&L

All costs shown as dollar amounts. Fixed costs broken out by category so every line is traceable. Phase bands show when bulk purchasing kicks in and COGS compresses.

Mo Revenue COGS Gross Profit Fees (17%) Salaries Operations Net Profit Cumulative
Phase 1 — small batch (26.5% COGS) Phase 2 — gallon/case scale (22% COGS) Phase 3 — first drum buys (18% COGS) Phase 4 — full drum scale (15% COGS)
Capital Deployment

How the $100,000 Total Capitalization Breaks Down

Both parties bring $50,000 to the table — one in cash, one in equipment, inventory, and expertise. Combined, the business launches fully capitalized with no debt and no gap in operations.

Use of Funds Breakdown

Land Owner — $50,000 Cash + Land Access

Cash deployed into container buildout ($30,000) and operating float ($10,000) to cover salaries, sampling, and content during the ramp period. Land access removes the need for commercial facility rental. No additional obligation beyond initial investment.

Christopher Shearer — $50,000 Equipment & Inventory

Extraction equipment, processing vessels, filling station, storage racking, and initial ingredient/packaging inventory — all sourced and in-hand. Plus 15+ years of extraction and lab design expertise running daily operations from day one.

Combined Result — Fully Operational at Month 4

No debt. No gap in production. The container is owned by Pure Extracts LLC — a mobile asset loadable on an 18-wheeler. Revenue is already at $1,500/month before the facility launches. Container facility removes the current production ceiling and drives the revenue ramp.

For the Land Partner

Land Owner ROI — 5% Equity Stake

The land owner brings $50,000 cash and land access. Christopher Shearer brings $50,000 in equipment and inventory plus the operations. In exchange for that capital and land, the land owner receives a 5% equity stake in Pure Extracts LLC — an ongoing share of a cash-flowing business built on their property.

What 5% Equity Means in Practice

The land owner receives 5% of net profit distributions, paid quarterly once the business is cash-flow positive (Month 6). That stake also represents 5% ownership in a company projected to carry an equity value of roughly $4.4M by Month 24 — based on a $122,500/month net profit run rate at a conservative 3× annual multiple. A 5% position at that point is worth approximately $220,000, independent of any cash already distributed.

TermDetail
Structure 5% equity stake in Pure Extracts LLC
Land owner contribution $50,000 cash investment + land access for container facility placement
Pure Extracts contribution $50,000 in extraction equipment + inventory + 15 years of expertise running daily operations
Distributions begin Month 12 — paid quarterly from that point forward
Year 1 projected distributions ~$2,550 5% × ~$51,000 net profit (M1–M12, back-loaded to M9–M12)
Year 2 projected distributions ~$41,750 5% × ~$835,000 net profit (M13–M24)
Total 24-month cash distributions ~$44,300 (5% × $886,000 cumulative net profit)
Estimated equity value at Month 24 ~$220,000 5% of ~$4.4M company value at 3× annual net profit multiple
After Month 24 Stake continues — distributions grow with revenue indefinitely. No expiration.
Land owner involvement None required — silent equity holder with quarterly financial reporting
Container / structure Owned by Pure Extracts LLC. Mobile asset — loadable on 18-wheeler. Does not transfer to land owner.
Operational Roadmap

Setup Timeline — Month by Month

M1

Site Agreement & Container Delivery

Partnership agreement executed. Shipping container delivered and placed. Site prep: gravel pad, electrical hookup run. Commercial kitchen operations continue in parallel — existing $1,500/mo revenue maintained throughout setup. No gap in production.

M2

Buildout — Electrical, Ventilation, Fixtures

C1D2-compliant interior build: explosion-proof electrical panel and outlets, vapor-tight LED lighting, inline exhaust ventilation system, epoxy floor coating, commercial sink and plumbing rough-in. Estimated 3–4 weeks of active work.

M3

Equipment Install + Inspection

Extraction equipment, mixing vessels, filling station, and storage racking installed. Fire marshal inspection for C1D2 classification. Texas DFA notification for food manufacturing. Final punchlist and commissioning.

M4

First On-Site Production Run

Full transition from commercial kitchen to on-site container. Batch sizes increase 3–5x due to dedicated scheduling and equipment scale. Revenue inflection begins. Commercial kitchen lease ended.

M6

Operational Breakeven — First Profitable Month

Net profit turns positive for the first time. Revenue projected ~$9,700/month. All operating costs covered from operations. Investment capital no longer needed for monthly overhead.

M9

Cumulative Breakeven

Total cumulative net profit crosses zero — all early-month losses recovered. Revenue ~$21,300/month. Wholesale account pipeline fully active. Platform revenue (Amazon, Etsy, eBay) contributing 10% of unit volume.

M12

Full Capital Recovery

Business has generated $50,000+ in cumulative net profit — fully validating the initial capital deployment. Revenue ~$46,800/month. Both salaries raise to $3,000 each. First 55-gallon drum purchases underway — COGS drops to 18% starting M13. Land partner equity distributions accelerating.

What We Make

Product Lines & Margins

SKU Wholesale T1 Retail COGS (Current) Gross Margin Format
Blue Lotus Resin$20$37.50$2.7586%1 oz jar
Blue Lotus Tincture$35$65.00$9.1874%2 oz dropper
Blue Lotus Gummies$20$42.50$4.1879%30-ct pouch
Blue Lotus Flower$15$32.50$4.4071%1 oz bag
Blue Lotus Elixir$50$110.00$13.9272%4 oz bottle
Kanna Alkaloid Extract$25$45.00$7.0072%5g jar
Kanna Tincture$35$67.50$10.2271%2 oz dropper
Kanna Gummies$20$37.50$5.2674%30-ct pouch
Kanna Fermented Herb$15$32.50$6.6756%1 oz bag
Kanna Elixir$50$110.00$19.6561%4 oz bottle